Agate Pass Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $571K | Buy |
8,269
+650
| +9% | +$44.9K | 0.23% | 80 |
|
|
2025
Q1 | $529K | Sell |
7,619
-400
| -5% | -$27.8K | 0.23% | 84 |
|
|
2024
Q4 | $690K | Sell |
8,019
-4,731
| -37% | -$407K | 0.31% | 78 |
|
|
2024
Q3 | $1.52M | Sell |
12,750
-475
| -4% | -$56.6K | 0.76% | 41 |
|
|
2024
Q2 | $1.89M | Sell |
13,225
-597
| -4% | -$85.2K | 1% | 33 |
|
|
2024
Q1 | $1.77M | Sell |
13,822
-549
| -4% | -$70.5K | 0.95% | 34 |
|
|
2023
Q4 | $1.49M | Buy |
14,371
+425
| +3% | +$44K | 0.86% | 37 |
|
|
2023
Q3 | $1.27M | Sell |
13,946
-710
| -5% | -$64.6K | 0.86% | 37 |
|
|
2023
Q2 | $1.19M | Sell |
14,656
-470
| -3% | -$38K | 0.72% | 41 |
|
|
2023
Q1 | $1.2M | Sell |
15,126
-250
| -2% | -$19.9K | 0.79% | 41 |
|
|
2022
Q4 | $1.04M | Buy |
15,376
+40
| +0.3% | +$2.71K | 0.74% | 42 |
|
|
2022
Q3 | $764K | Sell |
15,336
-360
| -2% | -$17.9K | 0.58% | 47 |
|
|
2022
Q2 | $875K | Buy |
15,696
+60
| +0.4% | +$3.35K | 0.62% | 47 |
|
|
2022
Q1 | $868K | Buy |
15,636
+900
| +6% | +$50K | 0.54% | 52 |
|
|
2021
Q4 | $825K | Buy |
+14,736
| New | +$825K | 0.51% | 54 |
|